NCT00591279

Brief Summary

This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 1981

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 1981

Completed
26.9 years until next milestone

First Submitted

Initial submission to the registry

December 26, 2007

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 11, 2008

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

35.9 years

First QC Date

December 26, 2007

Last Update Submit

September 11, 2023

Conditions

Colon Cancer

Keywords

large bowel cancerpolypscolorectal cancer

Outcome Measures

Primary Outcomes (1)

  • evaluate strategies for the surveillance of post-polypectomy patients

    6 years

Study Arms (2)

A

Barium enema and colonoscopy at one and three years after entry.

B

Barium enema and colonoscopy at three years only after entry.

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing colorectal cancer screening

You may qualify if:

  • referral for colonoscopy or
  • referral for proctoscopy or for a complete colonoscopy after a proctoscopy or flexible sigmoidoscopy

You may not qualify if:

  • prior history of colon cancer, unrelated polypectomy, inflammatory bowel disease, family history of familial polyposis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

fecal occult blood

MeSH Terms

Conditions

Colonic NeoplasmsPolypsColorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsRectal Diseases

Study Officials

  • Sidney Winawer, MD

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 26, 2007

First Posted

January 11, 2008

Study Start

February 1, 1981

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

September 13, 2023

Record last verified: 2023-09

Locations

US(1)